{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:55:45Z","timestamp":1786118145852,"version":"build-2736575974"},"reference-count":115,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["205321_204607"],"award-info":[{"award-number":["205321_204607"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_219969"],"award-info":[{"award-number":["310030_219969"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tips.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:16:00Z","timestamp":1783772160000},"page":"890-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surface-targeted complement modulation at biomedical interfaces"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0311-3305","authenticated-orcid":false,"given":"Ekaterina","family":"Umnyakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7106-1939","authenticated-orcid":false,"given":"Jannes","family":"Felsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-0233","authenticated-orcid":false,"given":"Daniel","family":"Ricklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.06.005_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100079","article-title":"The complement system: biology, pathology, and therapeutic interventions","volume":"77","author":"Li","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2026.06.005_bb0010","article-title":"Engineering the immune response to biomaterials","volume":"12","author":"Salehi Moghaddam","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.tips.2026.06.005_bb0015","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.3390\/jcm14082810","article-title":"Complement in antibody-mediated rejection of the kidney graft: from pathophysiology to clinical practice","volume":"14","author":"Sorohan","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tips.2026.06.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2025.100981","article-title":"Research progress on the complement system in ischemia-reperfusion injury of organ transplantation","volume":"40","author":"Zhang","year":"2026","journal-title":"Transplant. Rev. (Orlando)"},{"key":"10.1016\/j.tips.2026.06.005_bb0025","doi-asserted-by":"crossref","first-page":"27643","DOI":"10.1038\/s41598-025-11157-w","article-title":"Complement activation by the artificial surface of cardiopulmonary bypass is a persistent clinical problem","volume":"15","author":"Bierer","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2026.06.005_bb0030","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.ymthe.2024.12.019","article-title":"mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions","volume":"33","author":"Nguyen","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2026.06.005_bb0035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-022-01540-7","article-title":"Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression","volume":"41","author":"Gravina","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2026.06.005_bb0040","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: mechanisms, effects of complement inhibitors, and relevance to adverse reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0045","doi-asserted-by":"crossref","first-page":"28649","DOI":"10.1021\/acsnano.4c05087","article-title":"Nanoparticle-binding immunoglobulins predict variable complement responses in healthy and diseased cohorts","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101551","article-title":"Innate immune response to AAV-based gene therapy vectors: mechanisms of complement activation and cytokine release","volume":"33","author":"Xicluna","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tips.2026.06.005_bb0055","first-page":"243","article-title":"Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis","volume":"7","author":"Kaushik","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.tips.2026.06.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350816","article-title":"Complement-targeted therapeutics: are we there yet, or just getting started?","volume":"54","author":"Ricklin","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02539","article-title":"Current and future approaches for monitoring responses to anti-complement therapeutics","volume":"10","author":"Mohebnasab","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1021\/am900891h","article-title":"Effects of hydrophobicity and electrostatic charge on complement activation by amino groups","volume":"2","author":"Toda","year":"2010","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.tips.2026.06.005_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I \u2013 molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","article-title":"The classical pathway triggers pathogenic complement activation in membranous nephropathy","volume":"14","author":"Seifert","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.005_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cei\/uxac056","article-title":"The yin and the yang of early classical pathway complement disorders","volume":"209","author":"Sullivan","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0095","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3390\/ijms25031566","article-title":"The lectin pathway of the complement system\u2014activation, regulation, disease connections and interplay with other (proteolytic) systems","volume":"25","author":"Dob\u00f3","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00530","article-title":"Assessment of the role of C3(H2O) in the alternative pathway","volume":"11","author":"Fromell","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/eji.202149259","article-title":"Initial properdin binding contributes to alternative pathway activation at the surface of viable and necrotic cells","volume":"52","author":"van Essen","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00232-025-00343-6","article-title":"Action of the terminal complement pathway on cell membranes","volume":"258","author":"Ho","year":"2025","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.tips.2026.06.005_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1020889","article-title":"Membrane attack complexes, endothelial cell activation, and direct allorecognition","volume":"13","author":"Song","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","article-title":"Tipping the balance: intricate roles of the complement system in disease and therapy","volume":"43","author":"Pouw","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.tips.2026.06.005_bb0125","article-title":"Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.06.005_bb0130","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/biom13101522","article-title":"The molecular mechanisms of complement receptor 1\u2014it is complicated","volume":"13","author":"Hardy","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.tips.2026.06.005_bb0135","article-title":"The loss of glycocalyx integrity impairs complement factor H binding and contributes to cyclosporine-induced endothelial cell injury","volume":"10","author":"Teoh","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.tips.2026.06.005_bb0140","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3389\/fmicb.2016.02004","article-title":"Hijacking complement regulatory proteins for bacterial immune evasion","volume":"7","author":"Hovingh","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tips.2026.06.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100497","article-title":"Comirnaty-induced cardiopulmonary distress and other symptoms of complement-mediated pseudo-anaphylaxis in a hyperimmune pig model: causal role of anti-PEG antibodies","volume":"19","author":"Barta","year":"2024","journal-title":"Vaccine X"},{"key":"10.1016\/j.tips.2026.06.005_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/biom14010039","article-title":"The role of the complement system in the pathogenesis of infectious forms of hemolytic uremic syndrome","volume":"14","author":"Avdonin","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.tips.2026.06.005_bb0155","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1074\/jbc.M511563200","article-title":"Human C4b-binding protein, structural basis for interaction with streptococcal M protein, a major bacterial virulence factor","volume":"281","author":"Jenkins","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.06.005_bb0160","series-title":"FDA and CDER 03-31-2026 FDA identifies cases of serious liver injury in patients taking Tavneos (avacopan) for severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis","year":"2026"},{"key":"10.1016\/j.tips.2026.06.005_bb0165","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1021\/bi4003452","article-title":"Functional anatomy of complement factor H","volume":"52","author":"Makou","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2026.06.005_bb0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ymthe.2024.02.001","article-title":"C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement","volume":"32","author":"Liu","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2026.06.005_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.13156","article-title":"Alternative pathway diagnostics","volume":"313","author":"Thurman","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.tips.2026.06.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01692-24","article-title":"Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA)","volume":"69","author":"Thompson","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2026.06.005_bb0185","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/all.16231","article-title":"Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults","volume":"79","author":"Shah","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.tips.2026.06.005_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/vaccines13010014","article-title":"Regulating immune responses induced by PEGylated messenger RNA\u2013lipid nanoparticle vaccine","volume":"13","author":"Jo","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tips.2026.06.005_bb0195","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.vaccine.2023.05.029","article-title":"Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination","volume":"41","author":"Zhou","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.tips.2026.06.005_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-0716-3786-9_23","article-title":"Evaluation of the acute anaphylactoid reactogenicity of nanoparticle-containing medicines and vaccines using the porcine CARPA model","volume":"2789","author":"Szebeni","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tips.2026.06.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173510","article-title":"Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies","volume":"134","author":"Salabarria","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.06.005_bb0210","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/j.ymthe.2025.06.032","article-title":"Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophy","volume":"33","author":"Byrne","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2026.06.005_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000546114","article-title":"Eculizumab for thrombotic microangiopathy induced by onasemnogene abeparvovec in spinal muscular atrophy","volume":"15","author":"Kersnik Levart","year":"2025","journal-title":"Case Rep. Nephrol. Dial."},{"key":"10.1016\/j.tips.2026.06.005_bb0220","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ymthe.2024.05.004","article-title":"Engineered IgM and IgG cleaving enzymes for mitigating antibody neutralization and complement activation in AAV gene transfer","volume":"32","author":"Smith","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2026.06.005_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106537","article-title":"Protein corona formation on lipidic nanocapsules: influence of the interfacial PEG repartition","volume":"189","author":"Lebreton","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0230","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jconrel.2022.09.039","article-title":"Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles","volume":"351","author":"Moghimi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.005_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101479","article-title":"Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology","volume":"44","author":"Moghimi","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.tips.2026.06.005_bb0240","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1021\/acsnano.9b07218","article-title":"Premature drug release from polyethylene glycol (PEG)-coated liposomal doxorubicin via formation of the membrane attack complex","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.005_bb0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Estap\u00e9 Senti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.005_bb0250","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tips.2026.06.005_bb0255","first-page":"79","article-title":"Complement activation-related pseudo allergy of PEGylated products: safety aspects, models, the role of anti-PEG antibodies, and ways to overcome","volume":"5","author":"Mohamed","year":"2022","journal-title":"J. Adv. Biomed. Pharm. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0260","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s41467-025-56210-4","article-title":"Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles","volume":"16","author":"Shaw","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.005_bb0265","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.21037\/jtd.2017.03.134","article-title":"Thrombotic responses to coronary stents, bioresorbable scaffolds and the Kounis hypersensitivity-associated acute thrombotic syndrome","volume":"9","author":"Kounis","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.tips.2026.06.005_bb0270","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.athoracsur.2019.08.040","article-title":"Venoarterial-extracorporeal membrane oxygenation without routine systemic anticoagulation decreases adverse events","volume":"109","author":"Wood","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.tips.2026.06.005_bb0275","doi-asserted-by":"crossref","first-page":"11166","DOI":"10.3390\/ijms252011166","article-title":"Effect of unfractionated heparin dose on complement activation and selected extracellular vesicle populations during extracorporeal membrane oxygenation","volume":"25","author":"Zipperle","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/jcs6090244","article-title":"Recent developments and current challenges of heparin-grafted hemodialysis membranes","volume":"6","author":"Abdelrasoul","year":"2022","journal-title":"J. Compos. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188350","article-title":"The secret life of complement: challenges and opportunities in exploring functions of the complosome in disease","volume":"135","author":"Freiwald","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.06.005_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf135","article-title":"Role of intrarenal complement production in kidney transplantation","volume":"18","author":"Molinari","year":"2025","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.tips.2026.06.005_bb0295","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188346","article-title":"Emerging roles for complement in lung transplantation","volume":"135","author":"Kulkarni","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.06.005_bb0300","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41467-024-47131-9","article-title":"Enzymatic conversion of human blood group A kidneys to universal blood group O","volume":"15","author":"MacMillan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.005_bb0305","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ndt\/gfaf206","article-title":"Complement activation in kidney transplantation","volume":"41","author":"Kanbay","year":"2026","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tips.2026.06.005_bb0310","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175996","article-title":"C5 inhibition with eculizumab prevents thrombotic microangiopathy in a case series of pig-to-human kidney xenotransplantation","volume":"134","author":"Jones-Carr","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.06.005_bb0315","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jhep.2025.08.044","article-title":"Genetically engineered pig-to-human liver xenotransplantation","volume":"84","author":"Zhang","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tips.2026.06.005_bb0320","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa2412747","article-title":"Xenotransplantation of a porcine kidney for end-stage kidney disease","volume":"392","author":"Kawai","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2026.06.005_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2024.1485444","article-title":"Status of islet transplantation and innovations to sustainable outcomes: novel sites, cell sources, and drug delivery strategies","volume":"3","author":"Wong","year":"2024","journal-title":"Front. Transplant"},{"key":"10.1016\/j.tips.2026.06.005_bb0330","article-title":"Advancements in innate immune regulation strategies in islet transplantation","volume":"14","author":"Duan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jtct.2025.09.044","article-title":"Under the hood: evidence-based review of allogeneic chimeric antigen receptor T cells for hematologic malignancies","volume":"32","author":"Cheema","year":"2026","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.tips.2026.06.005_bb0340","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.3390\/cancers17172876","article-title":"Endothelial injury following CAR-T cell immunotherapy for hematological malignancies","volume":"17","author":"Demosthenous","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tips.2026.06.005_bb0345","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1182\/blood-2025-2328","article-title":"New evidence that complement activation and NLRP3 inflammasome signaling work together to cause cytokine release syndrome after CAR-T cell therapy","volume":"146","author":"Wierzbicka","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.tips.2026.06.005_bb0350","doi-asserted-by":"crossref","DOI":"10.1063\/5.0029994","article-title":"Antifouling strategies for protecting bioelectronic devices","volume":"9","author":"Chen","year":"2021","journal-title":"APL Mater."},{"key":"10.1016\/j.tips.2026.06.005_bb0355","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.xphs.2023.11.001","article-title":"Treatment-induced and pre-existing anti-peg antibodies: prevalence, clinical implications, and future perspectives","volume":"113","author":"Gaballa","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0360","article-title":"Novel surfaces in extracorporeal membrane oxygenation circuits","volume":"5","author":"Ontaneda","year":"2018","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.tips.2026.06.005_bb0365","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.athoracsur.2004.06.011","article-title":"A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients","volume":"78","author":"Lindholm","year":"2004","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.tips.2026.06.005_bb0370","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1177\/02676591241290924","article-title":"Comparable bleeding and inflammation outcomes between heparin-coated and uncoated minimal invasive extracorporeal circuits in isolated coronary artery bypass surgery \u2013 A double-blinded randomized control trial","volume":"40","author":"Jenni","year":"2025","journal-title":"Perfusion"},{"key":"10.1016\/j.tips.2026.06.005_bb0375","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.3390\/ijms252211975","article-title":"Hemocompatibility of albumin-modified magnetic nanoparticles","volume":"25","author":"Sharma","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0380","article-title":"Heparanase-induced endothelial glycocalyx degradation exacerbates lung ischemia\/reperfusion injury in male mice","volume":"12","author":"Noda","year":"2024","journal-title":"Phys. Rep."},{"key":"10.1016\/j.tips.2026.06.005_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1172892","article-title":"Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis","volume":"14","author":"Ying","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2023.04.110","article-title":"Albumin protects the ultrastructure of the endothelial glycocalyx of coronary arteries in myocardial ischemia-reperfusion injury in vivo","volume":"666","author":"Sawashita","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2026.06.005_bb0395","article-title":"Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0400","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ard.2025.06.2130","article-title":"Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigens","volume":"84","author":"Wang","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.tips.2026.06.005_bb0405","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.actbio.2022.10.055","article-title":"Complement-regulatory biomaterial coatings: activity and selectivity profile of the factor H-binding peptide 5C6","volume":"155","author":"Bechtler","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.tips.2026.06.005_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202500350","article-title":"Assay system based on metabolic glycoengineering-enabled click chemistry for the efficient evaluation of complement-regulatory peptide coatings on endothelial cells","volume":"12","author":"Felsch","year":"2025","journal-title":"Adv. Mater. Interfaces"},{"key":"10.1016\/j.tips.2026.06.005_bb0415","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.biomaterials.2009.01.001","article-title":"Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides","volume":"30","author":"Engberg","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.tips.2026.06.005_bb0420","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-097029","volume":"15","author":"Kassimatis","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.tips.2026.06.005_bb0425","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI17348","article-title":"Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation","volume":"111","author":"Song","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.06.005_bb0430","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1172\/JCI25208","article-title":"Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection","volume":"115","author":"Atkinson","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tips.2026.06.005_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105784","article-title":"Triple-fusion protein (TriFu): a potent, targeted, enzyme-like inhibitor of all three complement activation pathways","volume":"300","author":"Sonnentag","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.06.005_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117191","article-title":"Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeys","volume":"495","author":"Ruthsatz","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tips.2026.06.005_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100980","article-title":"CTx001 for geographic atrophy: a gene therapy expressing soluble, truncated complement receptor 1 (Mini-CR1)","volume":"6","author":"Rathi","year":"2026","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.tips.2026.06.005_bb0450","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.06.005_bb0455","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41565-023-01514-z","article-title":"Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins","volume":"19","author":"Li","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tips.2026.06.005_bb0460","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1039\/D3TB01721D","article-title":"Regulation of the innate immune system by fragmented heparin-conjugated lipids on lipid bilayered membranes in vitro","volume":"11","author":"Adler","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.tips.2026.06.005_bb0465","doi-asserted-by":"crossref","first-page":"12167","DOI":"10.1021\/acs.langmuir.4c01123","article-title":"Stealth and biocompatible gold nanoparticles through surface coating with a zwitterionic derivative of glutathione","volume":"40","author":"Guido","year":"2024","journal-title":"Langmuir"},{"key":"10.1016\/j.tips.2026.06.005_bb0470","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.biomaterials.2014.02.029","article-title":"On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s","volume":"35","author":"Ulbricht","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.tips.2026.06.005_bb0475","doi-asserted-by":"crossref","first-page":"12265","DOI":"10.1038\/s41598-021-91777-0","article-title":"Heparanase inhibition preserves the endothelial glycocalyx in lung grafts and improves lung preservation and transplant outcomes","volume":"11","author":"Noda","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2026.06.005_bb0480","doi-asserted-by":"crossref","first-page":"233","DOI":"10.21037\/hbsn-24-33","article-title":"Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation","volume":"14","author":"Rauter","year":"2025","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.tips.2026.06.005_bb0485","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13613-020-00697-1","article-title":"Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review","volume":"10","author":"Aldecoa","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.tips.2026.06.005_bb0490","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.ctm.2023.02.006","article-title":"The role of hyaluronan in endothelial glycocalyx and potential preventative lifestyle strategy with advancing age","volume":"91","author":"Lim","year":"2023","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.tips.2026.06.005_bb0495","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCRESAHA.121.318982","article-title":"Laminar flow on endothelial cells suppresses eNOS O-GlcNAcylation to promote eNOS activity","volume":"129","author":"Basehore","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2026.06.005_bb0500","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41551-021-00777-y","article-title":"Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers","volume":"5","author":"Siren","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tips.2026.06.005_bb0505","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M704354200","article-title":"C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack","volume":"282","author":"Trouw","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.06.005_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1281096","article-title":"Microbial evasion of the complement system: a continuous and evolving story","volume":"14","author":"Heggi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0515","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.4049\/jimmunol.1501388","article-title":"Complement evasion mediated by enhancement of captured factor H: implications for protection of self-surfaces from complement","volume":"195","author":"Herbert","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0520","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.4049\/jimmunol.1003802","article-title":"Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine","volume":"186","author":"Wu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102687","article-title":"Local complement inhibition by selective precision-targeted therapies","volume":"98","author":"Wang","year":"2026","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0530","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/01.CIR.101.5.541","article-title":"Soluble complement receptor-1 protects heart, lung, and cardiac myofilament function from cardiopulmonary bypass damage","volume":"101","author":"Chai","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tips.2026.06.005_bb0535","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.imbio.2014.10.026","article-title":"Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters","volume":"220","author":"Reis","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.tips.2026.06.005_bb0540","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12804","article-title":"Genetic knockout of porcine GGTA1 or CMAH\/GGTA1 is associated with the emergence of neo-glycans","volume":"30","author":"Morticelli","year":"2023","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.tips.2026.06.005_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.176725","article-title":"Stop \u201ctest-and-see\u201d: the evolved need for translational safety assessment in pharmaceutical biomaterials","volume":"538","author":"Fan","year":"2026","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.tips.2026.06.005_bb0550","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-025-57648-2","article-title":"Species differences in opsonization and phagocyte recognition of preclinical poly-2-alkyl-2-oxazoline-coated nanoparticles","volume":"16","author":"Tavano","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.005_bb0555","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1093\/jimmun\/vkaf053","article-title":"Tissue-targeted regulators of complement for amelioration of human disease: rationale and novel therapeutic strategies","volume":"214","author":"Liu","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0560","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/hum.2023.194","article-title":"Complement system response to adeno-associated virus vector gene therapy","volume":"35","author":"Kropf","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tips.2026.06.005_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1699894","article-title":"Endothelial dysfunction and hemostatic imbalance in CAR T-cell-associated toxicities: pathophysiological insights and the role of circulating biomarkers","volume":"16","author":"Moreno-Casta\u00f1o","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tips.2026.06.005_bb0570","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1089\/hum.2024.156","article-title":"Thrombotic microangiopathy associated with systemic adeno-associated virus gene transfer: review of reported cases","volume":"36","author":"Laforet","year":"2025","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tips.2026.06.005_bb3000","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113869","article-title":"The follicular dendritic cell: At the germinal center of autoimmunity?","volume":"43","author":"Krimpenfort","year":"2024","journal-title":"Cell Rep."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:10:48Z","timestamp":1786029048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726001446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0165614726001446"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.06.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-targeted complement modulation at biomedical interfaces","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}